Lastest Insider Transactions Of NovoCure Ltd ( NVCR ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
NVCR | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | 2024-03-01 | Sell | 2,519 | 16.02 | 40,358 | 2024-03-05 16:08:02 |
NVCR | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | 2024-02-27 | Sell | 2,078 | 16.14 | 33,545 | 2024-02-29 16:38:56 |
NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2024-02-27 | Sell | 2,303 | 16.14 | 37,177 | 2024-02-29 16:28:11 |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-11-07 | Sell | 382 | 12.65 | 4,832 | 2023-11-08 16:22:37 |
NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-10-31 | Option Exercise | 17,968 | 9.60 | 172,453 | 2023-11-02 16:20:51 |
NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-09-01 | Sell | 883 | 21.82 | 19,265 | 2023-09-05 16:24:39 |
NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-09-01 | Sell | 294 | 21.82 | 6,414 | 2023-09-05 16:24:18 |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-09-01 | Sell | 273 | 21.82 | 5,956 | 2023-09-05 16:23:32 |
NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-08-02 | Sell | 1,144 | 30.25 | 34,607 | 2023-08-04 16:02:21 |
NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-03-03 | Sell | 13,609 | 75.55 | 1,028,165 | 2023-03-07 16:52:16 |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-03-03 | Sell | 21,421 | 76.16 | 1,631,411 | 2023-03-07 16:52:00 |
NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-03-03 | Sell | 25,635 | 76.16 | 1,952,346 | 2023-03-07 16:51:48 |
NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-03-03 | Sell | 5,505 | 76.16 | 419,258 | 2023-03-07 16:51:15 |
NVCR | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | 2023-03-03 | Sell | 593 | 76.16 | 45,163 | 2023-03-07 16:50:35 |
NVCR | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | 2023-03-02 | Sell | 281 | 75.28 | 21,153 | 2023-03-06 16:42:42 |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-03-02 | Sell | 937 | 75.28 | 70,535 | 2023-03-06 16:41:07 |
NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-03-02 | Sell | 1,213 | 75.28 | 91,312 | 2023-03-06 16:40:52 |
NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-03-02 | Sell | 1,055 | 75.28 | 79,418 | 2023-03-06 16:40:12 |
NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-03-02 | Sell | 2,903 | 76.95 | 223,393 | 2023-03-06 16:37:48 |
NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-03-02 | Sell | 4,107 | 75.38 | 309,578 | 2023-03-03 16:13:03 |
NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-02-28 | Sell | 1,684 | 76.36 | 128,594 | 2023-03-02 17:01:17 |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | 2023-02-28 | Sell | 1,923 | 76.36 | 146,845 | 2023-03-02 17:00:09 |
NVCR | NovoCure Ltd | Cordova Ashley | Chief Financial Officer | 2023-02-28 | Sell | 2,198 | 76.36 | 167,845 | 2023-03-02 16:55:26 |
NVCR | NovoCure Ltd | Burke William Patrick | Chief Human Resources Officer | 2023-02-28 | Sell | 755 | 76.36 | 57,654 | 2023-03-02 16:51:19 |
NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-02-28 | Sell | 2,164 | 76.36 | 165,248 | 2023-03-02 16:49:32 |
NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Officer | 2023-01-05 | Sell | 8,143 | 116.14 | 945,756 | 2023-01-09 18:24:06 |
NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Officer | 2023-01-05 | Option Exercise | 1,946 | 47.04 | 91,540 | 2023-01-09 18:24:06 |
NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sell | 39,507 | 112.25 | 4,434,654 | 2023-01-09 18:21:59 |
NVCR | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Option Exercise | 35,209 | 15.39 | 541,697 | 2023-01-09 18:21:59 |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | 2023-01-05 | Sell | 387 | 108.00 | 41,796 | 2023-01-09 18:20:06 |
NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sell | 212,500 | 108.74 | 23,106,230 | 2023-01-09 18:18:44 |
NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Officer | 2023-01-05 | Option Exercise | 212,500 | 7.66 | 1,627,125 | 2023-01-09 18:18:44 |